The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III trial to evaluate the efficacy of uproleselan (GMI-1271) with chemotherapy in patients with relapsed/refractory acute myeloid leukemia.
 
Daniel J. DeAngelo
Consulting or Advisory Role - Amgen; ARIAD; Bristol-Myers Squibb; Celgene; Immunogen; Incyte; Novartis; Pfizer; Shire
 
Harry Paul Erba
Consulting or Advisory Role - Agios; Amgen; Astellas Pharma; Celgene; Daiichi Sankyo; Glycomimetics; Immunogen; Incyte; Jazz Pharmaceuticals; Macrogenics; Novartis; Pfizer; Seagen
Speakers' Bureau - Agios; Celgene; Incyte; Jazz Pharmaceuticals; Novartis
Research Funding - Agios (Inst); Amgen (Inst); Daiichi Sankyo (Inst); Glycomimetics (Inst); Immunogen (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Takeda (Inst)
Other Relationship - Celgene; Glycomimetics
 
Brian Andrew Jonas
Consulting or Advisory Role - Abbvie; Amgen; Jazz Pharmaceuticals; Tolero Pharmaceuticals
Research Funding - Abbvie (Inst); Accelerated Medical Diagnostics (Inst); Arog (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Esanex (Inst); FORMA Therapeutics (Inst); Genentech/Roche (Inst); Glycomimetics (Inst); Incyte (Inst); KaloBios (Inst); LP Therapeutics (Inst); Pharmacyclics (Inst)
 
Michael O'Dwyer
Research Funding - GlycoMimetics
 
Paula Marlton
Honoraria - Abbvie; Celgene; Janssen-Cilag; Novartis; Roche
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene; Janssen-Cilag; Novartis; Roche
Travel, Accommodations, Expenses - Roche
 
Gerwin A Huls
Research Funding - GlycoMimetics
 
Jane Liesveld
Research Funding - GlycoMimetics
 
Brenda W. Cooper
No Relationships to Disclose
 
Bhavana Bhatnagar
Research Funding - GlycoMimetics
 
Michael Armstrong
Other Relationship - GlycoMimetics
 
William Fogler
Employment - GlycoMimetics
Stock and Other Ownership Interests - GlycoMimetics
 
Mary Chen
Employment - GlycoMimetics
Stock and Other Ownership Interests - GlycoMimetics
 
John Magnani
Employment - GlycoMimetics
Leadership - GlycoMimetics
Stock and Other Ownership Interests - GlycoMimetics
 
Helen M. Thackray
Employment - GlycoMimetics
Stock and Other Ownership Interests - GlycoMimetics
 
Anjali S. Advani
Honoraria - EUSA Pharma; Pfizer; Sigma-Tau
Consulting or Advisory Role - Glycomimetics; Novartis; Pfizer; Seagen
Research Funding - KaloBios (Inst); Millennium (Inst); Pfizer (Inst); Seagen (Inst)
 
Pamela Sue Becker
Honoraria - Physicans' Education Resource; The France Foundation
Consulting or Advisory Role - CVS Caremark; McKesson; Pfizer; Pfizer (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); Aptose Biosciences (Inst); Bristol-Myers Squibb (Inst); Glycomimetics (Inst); Invivoscribe (Inst); JW Pharmaceutical (Inst); Novartis (Inst); Pfizer (Inst); Trethera (Inst); Trovagene (Inst)
Patents, Royalties, Other Intellectual Property - Provisional patent filed: Application 62/694,874 filed 7/6/2018 Entitled: "HIGH THROUGHPUT DRUG SCREENING OF CANCER STEM CELLS"
Travel, Accommodations, Expenses - The France Foundation